Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
North, You are without a doubt ahead of 90% of us - in character' - and awareness' - of importance of physical health if you plan to get old for real 🙂
------------------------
Even I (now 73) have lived a life with lots of physical use of muscle', running - cycling - heavy farm work - I'm not in the same League as you - when it comes to using science as a 'direct indicator' - of diet and general lifestyle.
------------------------
Hope / expect you to be 100+ - and still be making better calls than most of us - on the financial markets 🙂✌️
All the best
Jasbg
FSS, If you keep this up - I retract any further 'doubts' on your deep TA analyses !
If you can get us above $1 before to long I will shine your shoes 😀
JR, For a long time you were among the hardest critics of Denner - accusing him of being everything bad possible in the book on HFs,
---------------------------------------
Lately I read your posts the exact opposite on AMRN and Amarin - positive and constructive - actually arguing for a great future for the Company in a not to distant future.
Even being called not so nice names recently - I applaud 'the new You' - as one of the the posters here' that best - (despite the current depressing SP) - argues for the value and potentials of this haunted Company.
The God's of true helping our race to have a better' - healthier' - Longer life - will be listening here 😀
oneragman, Thanks for your suggestions in other Bios - but as Captain said - no more Bio stocks for him - my personal experience in Bio stocks will 'Live and die' with AMRN and Amarin.
And talking Amarin 'something has to happen soon'. Question is 'What / When' ?
Stock trading at $50 mill value below' Total Cash of the Company can't continue for long. Given simple logic Amarin in theory could buy up every stock out there (400+ mill) and still hold approx. $ 50 mill in cash.
Investing in AMRN is biggest loss of money in my adult life. From where I started shortly before R-I in autumn of 2018 till today AMRN stock loss - could have bought me 5- 6 brand new Tesla 3 Cars in Denmark.
---------------------------------
Hope I'm wrong - but feel a beginning depression is spreading amongst number of Longtime AMRN investors here on iHub AMRN board.
I own 62.000 shares - which is a lot less than 'a big number of posters here' - but as I said 'biggest loss of my life' - being in 'real working business' for more than 45 years of my life.
----------------------------------
Truth is - we were screwed by two gigantic Generic Companies in the Court of Nevada - and since then 6 more og the Generic parasites has joined the party - on the *Free Acces - to the 6 Patents Amarin used more than a decade to develop / gain exclusive rights to at the USPTO.
I as many others (who have lost even bigger) on the Nevada Ruling from marts' 2020 - based on Fraud - are still here' - Still hoping for justice to prevail in the end.
-----------------------------------
What' - truth be told - is seriously demoralising - after Sarissa / Denner takeover - is the ever sliding SP - and none to 'very little' info on where new Leadership Are' - in turning the hurting small Bio-company around.
What we need is 'Revenue - Revenue - Revenue !!!
Would going AG in the US (combined with - telling the public in a focused Add Campaign gain expanded Revenue / Prescriptions - it might be worth a shot !
Looking at value of AMRN stock - we are at a point of - not much to loose !
Whala, 20900 plus posts - and always the raised index finger - Warning against Amarin stock !!!
-------------------------------------------
I hope (absolutely trust and expect) - to live to see 'you Lose to Denner and Sarissa' - that will make Amarin Stock a Winner on World Markets ✌️
JR, Had you on Ignore - TROLL - for a long time !!
But as 'Ignored' persons appears in 'other debates' - STILL ended up - in the 'not understanding what the 'backdoor information on BRAVE Study' were all about.
---------------------------------------------------------
This is where iHub have a major PROBLEM !
You can put people on Ignore - but can stille see' and receive answers from the same posters - just the same.
---------------------------------------------------------
I Short - I didn't see your many post on the BRAVE mail from leading Scientist - as you were on 'ignore' on my account.
But as the Subject kept emerging - and I could/can see your correspondence 'secondary 'everywhere' else on iHub AMRN - we ended in a misguided konfrontation.
------------------------------------------------------------
I pointed this out before' - iHub have a problem in their *IGNORE function.
If you IGNORE a person - he/she shall be 'NON VISIABLE' everywhere on the given board - or the function 'is only adding to confusion' - as happened here !
JR, Thanks for the response - and tempered comments.
-----------------------------------------
Still wonder why a serious scientist would do something like that before official announcement.
But Ok - I do apologize for having overlooked your posts on the matter.
ramfan, Posted where' ???
Please link to 'the actual post' - telling a privat person 'results' of a serious Study via mail - long in advance of official announcements ?
JR, I newer saw you post it anywhere - copy of the actual mail from 'lead investigator' !!!
Why didn't you just post under your answer here again - and any doubt / debate would end ?
north, Here the "bad spirit" for Amarin - with Cramer -.from CNBC earlier january 2024:
https://www.cnbc.com/video/2024/01/09/cvs-ceo-karen-lynch-sits-down-with-jim-cramer.html
JR, Asked you before to put forward 'this magic email' - information you alone received - from lead investigator of the BRAVE Study ?
---------------------------------------------
It is a bit of a mystery,
What "lead investigator" - would send inside informations to a random private citizens - long before any official announcement on the Study ?
Whala, Again - again - again - 20800 plus ways in undermining trust in Amarin and Vascepa.
-----------------------------
Seriously - Other Bio's !!!
People on this board (unlike you) are many of them (us) invested BIG in Amarin - so please take your Pumping other Bio's to other boards !!!
Sleven, Thanks for posting (finding) this link. First official information on BRAVE Study for a long time.
MR.Fields, Could you maybe put a link here to where' there it is about the Brave Study, at the AAIC site - what you are referring to - thanks !
-------------------------------------------------------------
Or maybe Copy/Paste (cntl C / Cntl V) what ever text about the Brave Study - on the AAIC - (select quotes sign ('',,) press - cntl V - to set in copied text 😀
JR, Have to agree with you here. Denner and Sarissa 'likely have a lot of influence' on how Amarin is run - but as you said 'Denner is NOT on the board'.
And Hedge Funds works often in 'teams' - no way anyone can say that Sarissa is (not though partners) shorting Amarin - if they valuate that to be the best short term way to do business / make money.
-------------------------
And I am with you all the way - that Sarissa and Denner have 'big long term plans' for Amarin.
I like $10- 15 better than $5. BO announcement will be there some day - 2025 - 26 - not unlikely, if besides UK - a couple of other big countries in EU and possibly China - will start to create noticeable revenue ✌️
Capt, I thought about it a couple of times before sharing facts of our small country (5 mill people).
But in my experience the truth wins in the end.
Hopefully the 'ignorant reasons' given by danish authorities on this matter can be used in places 'that actually maters' for the future og Amarin - and then my little countrys 'experts' will surely have to acknowledge Vascepa/Vazkepa as being one of the most beneficial drugs ever' in keeping a 'good general health long as possible' 😀
Capt,
Tabel 2. Oplysninger om Vazkepa og øvrige lægemidler ud over statiner
Lægemiddel
(handelsnavn) Tilskudsstatus:
Pris per daglig dosis (kr.)* Vazkepa, icosapent ethyl, bløde kapsler - 67,25 kr. [998 mg]
Gemfibrozil, filmovertrukne tabletter/hård ekapsler (Lopid) Generelt klausuleret til patienter
med isoleret svær forhøjelse af triglycerid eller patienter med kombineret hyperlipidæmi evt. i
kombination med statin 2,57-13,58 kr. [300 mg; 600mg]
Ezetimib, tabletter (fx Ezetimibe ”Medical Valley”) Generelt tilskud 0,44-0,85 kr.
[10 mg] * Tilskudspris i takstperioden 1. november 2021 til 14. november 2021.
Capt, Your not correct about Denmark. VAZKEPA is approved but sadly 'no reimbursement'.
Many living in other places of the world - think that 'everything' regarding healt is free in Scandinavia - that is not true at all. Eg you have to pay big part of the bill at the dentist - and also part of 'even reimbursed medicine'.
Under here document (in danish) denying reimbursement of VAZKEPA.
https://laegemiddelstyrelsen.dk/da/tilskud/generelle-tilskud/afgoerelser/~/media/299C9E264F75408DBB14AB855F8A8FDB.ashx
Under here first part of document translated:
Vazkepa does not receive general or generally claused subsidies
Decision
Vazkepa, soft capsules containing icosapentethyl in the strength 998 mg do not get
general or generally claused subsidy.
Case preparation
On 29 June 2021, you applied for a general grant for Vazkepa, soft capsules with
content of icosapentethyl in the strength 998 mg (hereinafter Vazkepa).
Approved indication
Vazkepa is indicated to reduce the risk of cardiovascular events in
adult statin-treated patients at high cardiovascular risk with elevated
triglyceride values ??(= 150 mg/dl [= 1.7 mmol/l]) and
• diagnosed cardiovascular disease or
• diabetes and at least one other cardiovascular risk factor.1
Delivery group
Vazkepa is placed in extradition group B
Denisk, How much proof do you need - unless you say Amarin are lying - 'very publicly here' !
https://finance.yahoo.com/news/amarin-receives-national-reimbursement-vazkepa-201500835.html
Capt, Thanks for response. I'll dig into the links you provided a bit later (wife after me for spending to much time with the computer) 🙂
But glad you think 'there is hope - in having the science be noticed' - even the gigantic FO OTC industri is spreading information - that would fit very closely to the truth' for Vascepa' - not even 'in the same State' for prescription drug Lovaza - which could instead actually improve your risk of CDV problems !
-------------------------------
And look here - how Lovaza is presented to the public - as a Life Saver drug - with no health authorities (like FDA) interfering !
https://lovaza.com/
Capt, From where does most people get their knowledge (questions answered) these days: GOOGLE.
------------------------
Look what happens if i ask Google: 'omega 3 fish oil benefits'
Omega 3 lowers blood pressure, reduces triglycerides in the blood, helps reduce joint inflammation in rheumatoid disease, helps nourish brain and eyes functions, helps prevent and alleviate dementia, depression, asthma, migraine, and diabetes, and helps reduce the risk and preventing heart disease and ischemic stroke.7. jun. 2023
Nuke,
NTB, ANNE GRETE STORVIK
5 July 2024 at 08:36
The Ministry of Health and Care cancels the refusal from the Directorate for Medical Products in the processing of pre-approved reimbursement for the medicine Vazkepa (icosapentetyl).
"We have come to the conclusion that DMP has not had a good enough case management. As a consequence of this, we have come to the conclusion that the decision on refusal of pre-approved reimbursement is invalid, and must therefore be revoked", writes the Ministry of Health and Care to VG.
The case concerns the Directorate for Medical Products' (DMP) treatment of whether pre-approved reimbursement should be granted for the heart medicine Vazkepa, which means that it can be prescribed on a blue prescription.
The processing of such cases should take a maximum of 180 days, but the DMP took 614 days to process the case, which ended in a decision to reject it.
The pharmaceutical company Amarin, which markets the drug, appealed against the decision in September last year. They believed that the directorate had not made a real assessment of the complaint, that the wrong proof requirements had been used, and that they were exposed to unfair discrimination.
Unit leader Anette Grøvan in the DMP clarifies that the decision has been revoked, not overturned, and that it will now be processed again in the DMP.
The medicine has had marketing authorization in Norway since March 2021.
Sleven, That is good news - (hopefully - will be noticed also in Denmark):
We are only ½ way there though - but a least the chance of reimbursement ought to have good ods after Amarin complaint taken serious.
Enhetsleder Anette Grøvan i DMP presiserer at vedtaket er opphevet, ikke omgjort, og at den nå skal til ny behandling i DMP.
Lizzy, If you take the official announcement from Amarin for what it says - the org deal should be intact.
https://finance.yahoo.com/news/amarin-partner-eddingpharm-receives-regulatory-113000810.html
Under the partnership agreement, EDDING is responsible for development and commercialization activities in the China territory and associated expenses. Amarin provides development assistance and is responsible for supplying finished bulk product. Based upon the NMPA approval for the CVRR indication, Amarin will earn a regulatory milestone payment in the amount of $15 million. EDDING will also pay Amarin tiered double-digit percentage royalties on net sales of VASCEPA in the territory. Amarin will supply product to EDDING under negotiated supply terms.
Zip - Rose, Ok - understand the calculations. Still a lot of Chinese potential prescriptions - Thanks 😀
Zip, I dont know from were you have China population size - but I think it is rather to low 🙂
https://www.worldometers.info/world-population/china-population/
JR, That was all that my org. question to you was about - you confirming what you yourself suggested - at copy/paste - the Confirming mail from Brave research group here. I simply were interested to see the formulation in that letter - as this subject has been debated a lot here 'earlier.
---------------------------------------------------
Then Sleven comes out aggressively attacking that I asked a simple question - do anyone know where Amarin stands in the delisting process (being under $1- for now some time). Why that coursed - for this 'nonsense debate' who knows.
This self important guy sure has a short fuse - in his often provoking behavere.
Sleven, And you should likewise be embarrassed for starting 'the non factual' rumor 'Brave did not meet endpoint' - right.
I guess that it why you 'out of the blue' starts attacking people - as so often before.
Sleven, You bloated again - as so often before. This has nothing to do with you what so ever (beside - as I recall you actually started the rumor 'Brave not successful' - and ended being very offended 'on everyone' ).
--------------------------
Post were for JR - offering the other day 'to place his mail here - with Brave researchers saying endpoint not met' - shouldn't be that hard to understand with your sharp sense of logic.
JR, You promised couple of days ago to 'show mail proof' - of your korrespondance with responsible researchers behind the BRAVE study - that the study didn't meet the endpoints.
-------------------------
Haven't seen that response / proof for your 'talking Brave results down' - before the results are even published ?
Please - copy the mail in question here - for all to see - as you yourself surgested !!!
Whala, Thanks - your answer here 'actually comforting' - as far as 'the delisting goes' - as I read it !
------------------------
There is still time for Amarin - to regain trust in the future - second ½ of 2024. Taking SP above $1 would be good for a start - before to long ✌️
Whala, The bigger the 'Pump' - the better - as long as what spoken is the truth. Wee need all the help we can get right now !
-----------------------------
Anyone know 'how long to delisting' - has warning been given 'again' ?
North, Talking Ozempic - did you see the interview below ?
https://tuckercarlson.com/the-case-against-ozempic
liamlinden, Up $128k - did you sell then ? 🙂
Irish, Think you might just be right here.
-----------------------------------
Remember - some weeks back - he spins a story of 'his wife working from home' - him "accidently overhearing" - a talk with a patient of his wife - with no luck trying to defend the 'price for Vascepa' compared to a Statin.
His 'usual' - every chance placing needles in the confidence and trust in Amarin and Vascepa - this 'imaginary patient conference of his wife' - a little over the top in spinning - for anyone on this board to believe !
Whala, Will this be aloud to stand - as a result of the 2020- 21 World wide virus attack.
--------------------------------
Juli 4. coming up - a great tribute to your big Country - of combined very different States 🙂
JR, Every pro Day Trader 'Shorts' - every pro HF 'Shorts' - it is part of the game in the HF finance money world - given where Amarin stock is' at the moment.
------------------------------
What is important to remember here is - that a HF like Sarissara can/could invest 'in whatever stock in the marked - and 'Short' - if they felt it were 'best investment plan.
------------------------------
This is NOT what Sarissa and Denner have done around Amarin. There is clearly a long term strategy and plan - in using the effort and energy in taking on KM and 'old board' in the Proxy fight.
Truth is' where Amarin are' after the Du-disaster' (opening the door for FREE - for every aggressive generic company) - we couldn't have hoped for a better situation - than Sarissa and Denner taking over.
Lemm, Get your point. Honestly haven't followed the case very close.
You say its 'not about the fraudulent killed 6 patents' - but about infringement frem generics - on FDA CDV approval 2019.
And you are of course right - even it all started with the patents being disqualified - from 'not a chemist' - not a scientist - not a specialist in Bio.
Amarin were killed (not dead though) - by a populist liberal female judge - who really had no idea about the value of VASCEPA and the +10-year research by specialists - which she shoots down and undermines in seconds.
north, You have been a patent lawyer for 55 years - what I have heard. Legal stuff for me in the same period - i honestly know close to nothing about locally - even less in complex legal systems in the many states of America.
---------------------------
From your answer - I understand that in fact - an extension of patent period has happened in the Courts of US - even way back in time.
SP of AMRN after the current positive legal announcement shows' - that this is not 'in itself' something - that will blow Amarin out of the water bigtime'.
But still 'an important opening' for a change in the US - that has the potential of being significant in the not to far future :)